Detected ·
Cloverleaf Bio
$33M—
Cloverleaf Bio closed a $33M seed round led by 4BIO Capital, with participation from AbbVie Ventures, Eli Lilly and Company, Boehringer Ingelheim Venture Fund, Draper Associates, Mission BioCapital, and BrightEdge - American Cancer Society, to advance tRNA-based oncology therapeutics.
- Website
- —
- —
- Amount
- $33 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-09 04:36:22 UTC
- Signal ID
- 73857a9a-349c-4d93-ada5-b53ceaa13b80
As the API returns it
{
"id": "73857a9a-349c-4d93-ada5-b53ceaa13b80",
"created_at": "2026-09-09T04:36:22.128138Z",
"company_name": "Cloverleaf Bio",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 33000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Cloverleaf Bio closed a $33M seed round led by 4BIO Capital, with participation from AbbVie Ventures, Eli Lilly and Company, Boehringer Ingelheim Venture Fund, Draper Associates, Mission BioCapital, and BrightEdge - American Cancer Society, to advance tRNA-based oncology therapeutics.*"
}